ES2155537T3 - Imidas/amidas inmunoterapicas y su uso para reducir los niveles de tnf-alfa. - Google Patents

Imidas/amidas inmunoterapicas y su uso para reducir los niveles de tnf-alfa.

Info

Publication number
ES2155537T3
ES2155537T3 ES95940063T ES95940063T ES2155537T3 ES 2155537 T3 ES2155537 T3 ES 2155537T3 ES 95940063 T ES95940063 T ES 95940063T ES 95940063 T ES95940063 T ES 95940063T ES 2155537 T3 ES2155537 T3 ES 2155537T3
Authority
ES
Spain
Prior art keywords
immunotherapic
imidas
amidas
alfa
tnf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95940063T
Other languages
English (en)
Inventor
George Muller
Mary Shire
David I Stirling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Application granted granted Critical
Publication of ES2155537T3 publication Critical patent/ES2155537T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)

Abstract

LOS NUEVOS ETERES IMIDA/AMIDA SON INHIBIDORES DEL FACTOR DE NECROSIS TUMORAL {AL} Y SE PUEDEN UTILIZAR PARA COMBATIR LA CAQUEXIA, EL SHOCK ENDOTOXICO Y LA REPLICACION DE RETROVIRUS. UN EJEMPLO TIPICO ES EL 1 - FTALIMIDO - 1 - (3'',4'' DIMETOXIFENIL)PROPAN - 1 - OL.
ES95940063T 1994-12-30 1995-11-20 Imidas/amidas inmunoterapicas y su uso para reducir los niveles de tnf-alfa. Expired - Lifetime ES2155537T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36666794A 1994-12-30 1994-12-30

Publications (1)

Publication Number Publication Date
ES2155537T3 true ES2155537T3 (es) 2001-05-16

Family

ID=23443993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95940063T Expired - Lifetime ES2155537T3 (es) 1994-12-30 1995-11-20 Imidas/amidas inmunoterapicas y su uso para reducir los niveles de tnf-alfa.

Country Status (18)

Country Link
EP (1) EP0797437B1 (es)
JP (1) JPH10511678A (es)
AT (1) ATE200621T1 (es)
AU (1) AU696817B2 (es)
CA (1) CA2208672C (es)
CZ (1) CZ290372B6 (es)
DE (1) DE69520750T2 (es)
DK (1) DK0797437T3 (es)
ES (1) ES2155537T3 (es)
FI (1) FI972708A (es)
GR (1) GR3036131T3 (es)
HU (1) HU226558B1 (es)
NZ (1) NZ296925A (es)
PL (1) PL185101B1 (es)
PT (1) PT797437E (es)
RU (1) RU2164514C2 (es)
SK (1) SK86997A3 (es)
WO (1) WO1996020705A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
EP0818439B1 (en) * 1996-07-02 1999-10-13 Nisshin Flour Milling Co., Ltd. Imide derivatives
WO1998005333A1 (en) * 1996-08-05 1998-02-12 Molecumetics Ltd. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
EP1661566A3 (en) * 1996-08-05 2008-04-16 Myriad Genetics, Inc. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
US7091353B2 (en) 2000-12-27 2006-08-15 Celgene Corporation Isoindole-imide compounds, compositions, and uses thereof
US7320991B2 (en) 2001-02-27 2008-01-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health Analogs of thalidomide as potential angiogenesis inhibitors
US7498171B2 (en) 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
CA2808646C (en) 2003-09-17 2016-08-23 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Thalidomide analogs as tnf-alpha modulators
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992014455A1 (en) * 1991-02-14 1992-09-03 The Rockefeller University METHOD FOR CONTROLLING ABNORMAL CONCENTRATION TNF α IN HUMAN TISSUES
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines

Also Published As

Publication number Publication date
HUT77978A (hu) 1999-01-28
RU2164514C2 (ru) 2001-03-27
CZ290372B6 (cs) 2002-07-17
DE69520750T2 (de) 2001-09-13
PL185101B1 (pl) 2003-02-28
AU4166796A (en) 1996-07-24
AU696817B2 (en) 1998-09-17
WO1996020705A1 (en) 1996-07-11
PL321071A1 (en) 1997-11-24
PT797437E (pt) 2001-07-31
SK86997A3 (en) 1998-01-14
NZ296925A (en) 1998-06-26
FI972708A0 (fi) 1997-06-23
HU226558B1 (en) 2009-03-30
DK0797437T3 (da) 2001-06-05
JPH10511678A (ja) 1998-11-10
EP0797437B1 (en) 2001-04-18
CZ203597A3 (en) 1997-11-12
GR3036131T3 (en) 2001-09-28
CA2208672C (en) 2008-02-12
CA2208672A1 (en) 1996-07-11
EP0797437A1 (en) 1997-10-01
DE69520750D1 (de) 2001-05-23
FI972708A (fi) 1997-08-29
ATE200621T1 (de) 2001-05-15

Similar Documents

Publication Publication Date Title
DK0800514T3 (da) Substituerede imider som TNF inhibitorer
ES2165927T3 (es) Nuevas aril amidas inmunoterapeuticas.
DK0851857T3 (da) Inhibitorer af tumornekrosefaktor-alpha
PT862552E (pt) Succinimidas e maleimidas inibidoras de citocinas
ES2155537T3 (es) Imidas/amidas inmunoterapicas y su uso para reducir los niveles de tnf-alfa.
WO1998024763A3 (en) Immunotherapeutic imides/amides as pde iv and tnf inhibitors
MX9206687A (es) Metodos para preparar formas sinterizadas y composiciones utilizadas en los mismos.
EP0485111A3 (en) The use of lipoxygenase and cyclooxygenase inhibitors as synergistic agents
IT1145282B (it) Torre ad uso di refrigerante e oppure di camino e procedimento per realizzarla
BR9204211A (pt) Composto,composicao herbicida,processo para exterminar ervas daninhas e uso do dito composto
ES2134667T3 (es) Empleo de un enganche para mosquitera.
GB8926611D0 (en) Compound and its use
ES2158441T3 (es) Arilheterociclos con actividad herbicida.
SE8002608L (sv) N-(4-azido-5-(2-etoxietyl)-6-fenyl-2-pyrimidinyl)-acetamid och beslektade foreningar
IT8149929A0 (it) Apparecchiatura di difesa anti-se questro di persona e anti-rapina senza uso di armi da fuoco
DK220385D0 (da) Fremgangsmaade til fremstilling af oxadiazolylderivater af imidazobenzodiazepiner og mellemprodukt til brug ved fremgangsmaaden
IT8519659A0 (it) Procedimento per riunire le estre mita'di spezzoni di catenelle a pallini,nonche'dispositivo per lasua attuazione e giunto utilizzato
PT7710T (pt) Gerador portatil de ar quente e de vapor para sauna de uso domestico

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 797437

Country of ref document: ES